Inheritance of moyamoya disease in a Caucasian family

European Journal of Neurology

Volumn 19, Issue 3, 2012, Pages 438-442

  Kraemer, M ^a   Heinemann, F M ^b   Horn, P A ^b   Venker, C ^a   Berlit, P ^a   Krischek, B ^c   Khan, N ^d  

^a Alfried Krupp von Bohlen und Halbach Hospital   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Autosomal dominant; Caucasian; Father to child inheritance pattern of moyamoya disease

Indexed keywords

HLA A2 ANTIGEN; HLA A24 ANTIGEN; HLA ANTIGEN; HLA B18 ANTIGEN; HLA B58 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; APHASIA; ARTERIOSCLEROSIS; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CASE REPORT; CAUCASIAN; DEPRESSION; FAMILY HISTORY; HEADACHE; HEMIPARESIS; HLA TYPING; HUMAN; INHERITANCE; MALE; MOYAMOYA DISEASE; PRESYNCOPE; PRIORITY JOURNAL; REVASCULARIZATION; TOBACCO DEPENDENCE;

ADULT; DISEASE SUSCEPTIBILITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; MOYAMOYA DISEASE; PEDIGREE; STROKE; YOUNG ADULT;

EID: 84857053749     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03536.x     Document Type: Article

References (35)

1. Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke 2008; 39: 3193-3200.
2. Kramer M, Berlit P. [Moyamoya disease - a rare vasculopathy in Europeans]. Fortschr Neurol Psychiatr 2010; 78: 542-550; quiz 551.
3. Khan N, Schuknecht B, Boltshauser E, et al. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures. Acta Neurochir (Wien) 2003; 145: 1061-1071; discussion 1071.
4. Khan N, Yonekawa Y. Moyamoya angiopathy in Europe. Acta Neurochir Suppl 2005; 94: 149-152.
5. Kraemer M, Berlit P. Primary central nervous system vasculitis and moyamoya disease: similarities and differences. J Neurol 2010; 257: 816-819.
6. Krischek B, Kasuya H, Khan N, Tatagiba M, Roder C, Kraemer M. Genetic and clinical characteristics of Moyamoya disease in Europeans. Acta neurochir Suppl 2011; 112: 31-34.
7. Khan N, Yonekawa Y. Moyamoya angiopathy in Europe: the beginnings in Zurich, practical lessons learned, increasing awareness and future perspectives. Acta Neurochir Suppl 2008; 103: 127-130.
8. Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof HG. Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 1997; 99(Suppl 2): S58-S60.
9. Achrol AS, Guzman R, Lee M, Steinberg GK. Pathophysiology and genetic factors in moyamoya disease. Neurosurg Focus 2009; 26: E4.
10. Park MH, Hong SH, Wang K-C. HLA Studies in Moyamoya Disease. In: Cho BK, Tominaga T eds. Moyamoya Disease Update. edn. New York: Springer, 2010: 54-63.
11. Roder C, Nayak NR, Khan N, Tatagiba M, Inoue I, Krischek B. Genetics of Moyamoya disease. J Hum Genet 2010; 55: 711-716.
12. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997; 99(Suppl 2): S238-S240.
13. Guo DC, Papke CL, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 2009; 84: 617-627.
14. Milewicz DM, Ostergaard JR, Ala-Kokko LM, et al. De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet A 2010; 152A: 2437-2443.
15. Herve D, Touraine P, Verloes A, et al. A hereditary moyamoya syndrome with multisystemic manifestations. Neurology 2010; 75: 259-264.
16. Miskinyte S, Butler MG, Herve D, et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet 2011; 88: 718-728.
17. Oudshoorn M, Horn PA, Tilanus M, Yu N. Typing of potential and selected donors for transplant: methodology and resolution. Tissue Antigens 2007; 69(Suppl 1): 10-12.
18. Mineharu Y, Takenaka K, Yamakawa H, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry 2006; 77: 1025-1029.
19. Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 2000; 15: 179-182.
20. Kitahara T, Okumura K, Semba A, Yamaura A, Makino H. Genetic and immunologic analysis on moya-moya. J Neurol Neurosurg Psychiatry 1982; 45: 1048-1052.
21. Aoyagi M, Ogami K, Matsushima Y, Shikata M, Yamamoto M, Yamamoto K. Human leukocyte antigen in patients with moyamoya disease. Stroke 1995; 26: 415-417.
22. Inoue TK, Ikezaki K, Sasazuki T, et al. DNA typing of HLA in the patients with moyamoya disease. Jpn J Hum Genet 1997; 42: 507-515.
23. Han H, Pyo CW, Yoo DS, Huh PW, Cho KS, Kim DS. Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population. J Korean Med Sci 2003; 18: 876-880.
24. Hong SH, Wang KC, Kim SK, Cho BK, Park MH. Association of HLA-DR and -DQ Genes with Familial Moyamoya Disease in Koreans. J Korean Neurosurg Soc 2009; 46: 558-563.
25. Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999; 64: 533-537.
26. Yamauchi T, Tada M, Houkin K, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 2000; 31: 930-935.
27. Mineharu Y, Liu W, Inoue K, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 2008; 70(24 Pt 2): 2357-2363.
28. Andreone V, Ciarmiello A, Fusco C, Ambrosanio G, Florio C, Linfante I. Moyamoya disease in Italian monozygotic twins. Neurology 1999; 53: 1332-1335.
29. Arai K, Yamasaki Y, Kajimoto Y, et al. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid arterial wall thickening and myocardial infarction risk in NIDDM. Diabetes 1997; 46: 2102-2104.
30. Shetty-Alva N, Alva S. Familial moyamoya disease in Caucasians. Pediatr Neurol 2000; 23: 445-447.
31. Zafeiriou DI, Ikeda H, Anastasiou A, et al. Familial moyamoya disease in a Greek family. Brain Dev 2003; 25: 288-290.
32. Setzen G, Cacace AT, Eames F, et al. Central deafness with a young child with Moyamoya disease: Paternal linkage in a Caucasian family: two case reports and review of the literature. Int J Pediatr Otorhinolaryngol 1999; 48: 53-76.
33. Roder C, Peters V, Kasuya H, et al. Analysis of ACTA2 in European Moyamoya disease patients. Eur J Paediatr Neurol 2011; 15: 117-122.
34. Roder C, Peters V, Kasuya H, et al. Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients. Acta Neurochir (Wien) 2010; 152: 2153-2160.
35. Roder C, Peters V, Kasuya H, et al. Common genetic polymorphisms in moyamoya and atherosclerotic disease in Europeans. Childs Nerv Syst 2011; 27: 245-252.